Heron Therapeutics | HRTX - 시가 총액

주가
0.85
매일 변경
0.03 4.10%
매월
-12.06%
매년
-55.34%
Q2 예상
0.83




시가 총액 변화 날짜
ALKERMES USD 4.62B 333M 2025-12
Alnylam Pharmaceuticals USD 52.54B 7.24B 2025-12
Amarin USD 290M 51M 2025-12
ANI Pharmaceuticals USD 1.77B 269M 2025-12
Anika Therapeutics USD 139M 3M 2025-12
Arrowhead Research USD 9.02B 4.25B 2025-12
Eisai JPY 1.31T 140.95B 2025-12
Emergent BioSolutions USD 125M 51M 2023-12
Esperion Therapeutics USD 885M 351M 2025-12
GlaxoSmithKline GBP 74.36B 10.31B 2025-12
Heron Therapeutics USD 238M 7M 2025-12
Insmed USD 37.12B 6.68B 2025-12
Merck USD 261.26B 51.62B 2025-12
Nektar Therapeutics USD 14.34B 13.48B 2026-04
Neurocrine Biosciences USD 14.14B 218M 2025-12
Pacira USD 1.06B 94M 2025-12
Regeneron Pharmaceuticals USD 81.12B 21.53B 2025-12
Roche Holding CHF 266.34B 55.46B 2025-12
Ultragenyx Pharmaceutical USD 2.22B 680M 2025-12
Veracyte USD 3.33B 627M 2025-12
Vertex Pharmaceuticals USD 115.03B 14.61B 2025-12